The "GJB6 Gene Deafness Autosomal Dominant Type 3B Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GJB6 gene, which are associated with Autosomal Dominant Deafness Type 3B (DFNA3B). This condition is a form of genetic hearing loss where the affected individual inherits the mutated gene from one parent, leading to varying degrees of hearing impairment that can present at any age.
The GJB6 gene plays a crucial role in the function of cochlear hair cells and the maintenance of potassium levels in the inner ear, which are essential for normal hearing. Mutations in this gene disrupt these processes, leading to hearing loss.
The test is conducted using a sample of the patient's DNA, typically extracted from a blood sample or cheek swab. The genetic material is then analyzed using advanced molecular techniques to identify any mutations in the GJB6 gene.
Priced at 4400 AED, this test is a critical tool for individuals with a family history of hearing loss, offering them valuable insights into their genetic predisposition. Early detection through this test can facilitate timely interventions and management strategies, improving the quality of life for those affected. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes for patients seeking clarity on their genetic health.
The MYH14 gene, associated with Deafness Autosomal Dominant Type 4, plays a crucial role in the development and function of the auditory system. Mutations in this gene can lead to hearing impairment, making it a significant focus for genetic testing in individuals experiencing hearing loss with a suspected genetic basis.
The genetic test for MYH14-related deafness is a comprehensive analysis designed to detect mutations within the MYH14 gene that are known to cause Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL). This form of hearing loss is characterized by its inheritance pattern, where a single copy of the altered gene in each cell is sufficient to cause the condition, and it typically does not affect other body systems.
At DNA Labs UAE, the test for MYH14 gene-related deafness is offered at a cost of 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing technologies. This test is not only crucial for diagnosing affected individuals but also for understanding the risk of passing the condition to future generations, thereby aiding in informed family planning decisions.
Individuals who have a family history of hearing loss or have been diagnosed with hearing impairment without a known cause are potential candidates for this test. It provides a definitive diagnosis, enabling healthcare providers to offer tailored advice and management strategies for those affected by hearing loss associated with the MYH14 gene.
The CRYM Gene Deafness Autosomal Dominant Type 40 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CRYM gene that are associated with Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) type 40. This condition, which can affect individuals of any age, is characterized by varying degrees of hearing impairment that can range from mild to profound. The test is crucial for early detection and management of the condition, enabling healthcare providers to offer appropriate interventions and support for affected individuals and their families.
Conducted through a simple yet sophisticated process that involves the collection and analysis of a DNA sample, typically obtained via a blood draw or cheek swab, the test scrutinizes the CRYM gene for specific genetic alterations known to contribute to this form of hearing loss. By identifying these mutations, the test not only confirms a diagnosis but also helps in understanding the inheritance pattern within a family, thereby aiding in future family planning and providing insights into the condition's progression and potential treatments.
The cost of the CRYM Gene Deafness Autosomal Dominant Type 40 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis necessary to provide a detailed and accurate understanding of an individual's genetic predisposition to this form of deafness, offering invaluable information for affected individuals and their healthcare providers.
The TAT Gene Tyrosinemia Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the TAT gene, which are responsible for Tyrosinemia type 2, a rare metabolic disorder. This condition is characterized by elevated levels of tyrosine in the blood, leading to issues such as skin lesions, eye problems, and, in some cases, intellectual disability. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any genetic alterations in the TAT gene, providing crucial information for accurate diagnosis and enabling targeted treatment approaches. By identifying the specific mutations causing Tyrosinemia type 2, healthcare providers can offer personalized management plans to mitigate the symptoms and improve the quality of life for affected individuals.
The HPD Gene Tyrosinemia Type 3 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the HPD gene, which are associated with Tyrosinemia type 3, a rare metabolic disorder. This condition results from the body's inability to effectively break down the amino acid tyrosine, leading to various health issues, including intellectual disabilities, seizures, and liver problems. Early detection through this genetic test can enable timely intervention and management of the condition, potentially mitigating severe outcomes. The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, offering the test at a cost of 4400 AED. This test is crucial for individuals with a family history of Tyrosinemia or those showing symptoms related to the disorder, providing them with essential insights into their genetic health.
The ECM1 gene Urbach-Wiethe disease genetic test is a specialized diagnostic tool used to identify mutations in the ECM1 gene, which are associated with Urbach-Wiethe disease (UWD), a rare genetic disorder. This condition is characterized by a variety of symptoms, including skin thickening, hoarseness of voice, and, in some cases, neurological issues due to calcium deposits in the brain. The ECM1 gene plays a critical role in skin integrity and structure, and mutations in this gene can lead to the hallmark features of UWD.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in a laboratory to identify any genetic abnormalities in the ECM1 gene. This genetic test is crucial for the accurate diagnosis of Urbach-Wiethe disease, enabling healthcare providers to offer appropriate management and treatment options for affected individuals.
The ECM1 gene Urbach-Wiethe disease genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the specialized nature of the testing and the expertise required to interpret the results. By offering this test, DNA Labs UAE provides an essential service for patients and families affected by Urbach-Wiethe disease, facilitating early diagnosis and intervention for this rare genetic condition.
The G6PC gene plays a crucial role in the body's glucose metabolism. Mutations in this gene are responsible for a condition known as Von Gierke disease, also known as Glycogen Storage Disease Type Ia (GSD Ia). This inherited disorder affects the liver and kidneys' ability to regulate blood sugar levels, leading to symptoms such as hypoglycemia, lactic acidosis, hyperuricemia, and growth retardation.
To diagnose Von Gierke disease and confirm a genetic mutation in the G6PC gene, a genetic test is available. DNA Labs UAE offers this specific test, providing a crucial tool for individuals suspecting they or their family members may have this condition. The test involves analyzing the DNA to identify mutations in the G6PC gene that are indicative of Von Gierke disease.
The cost of the G6PC Gene Von-Gierke Disease Genetic Test at DNA Labs UAE is 4400 AED. This test is essential for accurate diagnosis, enabling targeted management and treatment plans for affected individuals. It also provides valuable information for family planning and the assessment of risk in future offspring.
The ATP7B gene Wilson disease genetic test is a diagnostic tool used to identify mutations in the ATP7B gene, which are responsible for Wilson disease, a rare autosomal recessive disorder. This genetic condition leads to excessive accumulation of copper in the body, affecting the liver, brain, and other organs. Early detection through genetic testing is crucial for managing symptoms and preventing severe complications. The test involves analyzing the DNA to look for specific mutations in the ATP7B gene that are known to cause Wilson disease.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the ATP7B gene test is available for a cost of 4400 AED. This comprehensive test offers individuals and families critical information regarding the genetic predisposition to Wilson disease, enabling timely intervention and appropriate management strategies. By choosing DNA Labs UAE for this test, patients can expect accurate results, professional confidentiality, and guidance on the implications of the test outcomes.
The LIPA Gene Wolman Disease Genetic Test is a specialized diagnostic tool designed to identify mutations in the LIPA gene, which are responsible for Wolman disease. This rare genetic disorder is characterized by the body's inability to properly break down fats, leading to significant health issues such as malabsorption, liver dysfunction, and adrenal gland problems. Early detection through this genetic test can be crucial for managing symptoms and improving the quality of life for affected individuals.
The test is performed by DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the LIPA Gene Wolman Disease Genetic Test is set at 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the LIPA gene. The results from this test can provide valuable information for families and healthcare providers, enabling them to make informed decisions regarding treatment and care for those diagnosed with Wolman disease.
The XDH Gene Xanthinuria Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the XDH gene that are associated with Xanthinuria Type 1. This rare genetic disorder impacts the body's ability to metabolize purines, leading to an accumulation of xanthine, which can result in kidney stones, kidney failure, and occasionally muscle disease. The test involves analyzing the patient's DNA to identify any genetic alterations in the XDH gene that might lead to the condition. With a cost of 4400 AED, the test provides crucial information for the accurate diagnosis and management of Xanthinuria Type 1, enabling targeted treatment plans and lifestyle adjustments to mitigate the risk of complications associated with this disorder. DNA Labs UAE, known for its advanced genetic testing services, offers this test as part of its commitment to providing comprehensive diagnostic solutions for rare genetic conditions.
